Cardium Therapeutics Boosts Energy Supplement Sales(0) A recent article on San Diego Biotechnology Connection: Cardium boosts energy supplement sales with national marketing muscle Cardium Therapeutics’ purchase of To Go Brands and its nationwide marketing network is expected to boost energy supplement sales of Cardium’s MedPodium line, including Neo-Chill, which promotes relaxation without drowsiness and contains Suntheanine, a patented, proprietary L-theanine (an amino acid) also found in green tea. Read More |
Cardium Increases Product Portfolio with Acquisition of To Go Brands(0) Cardium Therapeutics (NYSE MKT: CXM) today announced that its MedPodium® operating unit has acquired the assets, business and product portfolio of privately-held To Go Brands® to support the expansion of Cardium’s health sciences nutraceutical brand platform. To Go Brands have introduced products in a number of food, drug and mass channel retailers, and the company recorded revenues of approximately $1.7 million for the first 6 months of 2012. Read More |
Genesis Completes Acquisitions of ADEX and TNS(0) Utilizing $13 million in proceeds from a MidMarket Capital loan, Genesis Group Holdings, Inc. (OTCBB: GGHO), a holding company operating through its subsidiaries to provide solutions in the telecommunications and mobile industries, reported today that they have completed two acquisitions of revenue generating companies. The finalized merger will bring Genesis to positive earnings and operational cash flow, according to Read More |
Xstrata and Glencore Agree to Merger Terms, Shareholders Disagree with Deal(0) The discussion talks were confirmed last week by Xstrata PLC (LSE:XTA, Pink Sheets:XSRAY) that it and Glencore International PLC (LSE:GLEN) were considering a merger, although careful to say that no assurance was given that a deal would ever materialize. This morning, that deal came public with the two industry giants agreeing to merge in an all-share deal that would create a $90 billion natural resources behemoth. Read More |
Valeant Pulls Offer to Buy ISTA Pharmaceuticals(0) As a result of what Valeant Pharmaceuticals International Inc. (NYSE:VRX, TSX:VRX) called “a lack of progress,” Valeant has withdrawn its offer to buy ISTA Pharmaceuticals Inc. (NASDAQ:ISTA) for $7.50 a share in cash. Valeant had been aggressive in its efforts to acquire California-based ISTA, increasing the offer from $6.50 to $7.50 earlier this month and stating that the offer could go as high as Read More |
Everything for Less Equals More, Pep Boys Accepts Offer at $15 A Share(0) Pep Boys may have everything for less, but today they got more. Pep Boys – Manny Moe & Jack (NYSE:PBY), the U.S.’s largest automotive aftermarket service and retail chain said this morning that it is going private via a definitive merger agreement to be acquired by The Gores Group, one of the country’s leading investment firms. The agreement is valued at approximately $1 billion, or $15 per share for holders of PBY. Read More |
Contacts and informationHave an opinion or news that you want to share?
|
Social networks |
Most popular categories |